|
Name quidel
|
Cat. #
|
Quantity
|
|
MicroVue DPD EIA quidel
|
8007
|
1 kit
|
|
MicroVue PYD EIA quidel
|
8010
|
1 kit
|
|
MicroVue BAP EIA quidel
|
8012
|
1 kit
|
|
MicroVue Calcitonin EIA
|
8043
|
1 kit
|
|
MicroVue Intact PTH EIA
|
8044
|
1 kit
|
|
MicroVue 25-OH Vitamin D EIA
|
8046
|
1 kit
|
|
MicroVue Osteocalcin EIA*
|
8002
|
1 kit
|
|
MicroVue CICP EIA*
|
8003
|
1 kit
|
|
MicroVue Creatinine EIA*
|
8009
|
1 kit
|
|
MicroVue Serum PYD EIA*
|
8019
|
1 kit
|
|
MicroVue YKL-40 EIA*
|
8020
|
1 kit
|
|
MicroVue Helical Peptide EIA*
|
8022
|
1 kit
|
|
MicroVue tDPD EIA*
|
8032
|
1 kit
|
|
MicroVue TRAP5b EIA*
|
8033
|
1 kit
|
|
MicroVue OPG EIA*
|
8034
|
1 kit
|
|
Human Sclerostin HS EIA*
|
TE1023HS
|
1 kit
|
|
Human Hyaluronic Acid Plus EIA*
|
TE1018-2
|
1 kit
|
|
Human Intact Proinsulin ELISA*
|
TE1011
|
1 kit
|
|
Human Leptin ELISA*quidel(quidel corporation)代理
|
TE1016
|
1 kit
|
|
Total Human Adiponectin ELISA*
|
TE1014
|
1 kit
|
|
Streptavidin Coated 96-well Plate (for biotinylated molecules)
|
4634
|
1 each
|
|
Wash Buffer Concentrate
|
4703
|
55 mL
|
|
Assay Buffer
|
4704
|
55 mL
|
|
Hydrolysis Unit
|
4838
|
1 each
|
|
30k MWCO Spinfilters
|
4935
|
40/bag
|
|
CICP Controls – serum*
|
4818
|
set of 4
|
|
Osteocalcin Controls – serum*
|
4819
|
set of 4
|
|
BAP Controls – serum*
|
4820
|
set of 4
|
|
YKL-40 Controls*
|
4821
|
set of 3
|
|
Dpd Controls – urine*
|
4822
|
set of 4
|
|
Pyridinoline Controls – urine*
|
4823
|
set of 4
|
|
Pyridinoline Controls – serum*
|
4824
|
set of 4
|
|
Helical Peptide Controls – urine*
|
4936
|
set of 4
|
|
Pyd/Dpd HPLC Calibrator*
|
8004
|
770 µL
|
|
HPLC Internal Standard*
|
8006
|
5 mL
|
|
Mouse Anti-CICP antibody*
|
4817
|
0.1 mg
|
|
H-Dpd*
|
4807
|
0.02 mg
|
|
Mouse Anti-Dpd antibody*
|
4811
|
0.1 mg
|
|
H-Pyd*
|
4805
|
0.02 mg
|
|
Mouse Anti-Pyd antibody*
|
4809
|
0.1 mg
|
|
Mouse Anti-YKL-40 antibody*
|
4813
|
0.1 mg
|
|
Rabbit Anti-YKL-40 antibody*
|
4815
|
0.1 mg
|
|
YKL-40 Purified Protein*
|
A442
|
25 µg
|
|
MicroVue CIC-C1q EIA quidel(quidel corporation)代理
|
A001
|
1 kit
|
|
MicroVue CIC Raji Cell Replacement EIA quidel
|
A002
|
1 kit
|
|
MicroVue CIC-C1q Controls (Low and High Control)
|
A013
|
1 ea.
|
|
MicroVue CH50 Eq EIA
|
A018
|
1 kit
|
|
MicroVue Bb Plus Fragment EIA quidel
|
A027
|
1 kit
|
|
MicroVue C1 Inhibitor Plus EIA
|
A037
|
1 kit
|
|
EIA Kits for Assessment of Complement Activation
|
|
|
|
MicroVue iC3b Fragment EIA – For Research Use Only
|
A006
|
1 kit
|
|
MicroVue C4d Fragment EIA – For Research Use Only
|
A008
|
1 kit
|
|
MicroVue SC5b-9 Plus EIA – For Research Use Only
|
A020
|
1 kit
|
|
MicroVue C5a EIA – For Research Use Only
|
A021
|
1 kit
|
|
MicroVue C3a Plus EIA – For Research Use Only
|
A031
|
1 kit
|
|
MicroVue Ba Fragment EIA – For Research Use Only
|
A033
|
1 kit
|
|
MicroVue C4a EIA – For Research Use Only
|
A035
|
1 kit
|
|
MicroVue Animal Pan-Specific C3 Reagent Kit – For Research Use Only
|
20261
|
1 kit
|
|
MBL Oligomer EIA – For Research Use Only
|
BP029
|
1 kit
|
|
EIA Kits for Assessment of Prekallikrein Activator Level
|
|
|
|
Prekallikrein Activator (PKA) Assay Kit
|
PW30100
|
1 kit
|
|
Prekallikrein Activator (PKA) EP Assay Kit
|
PW301EP
|
1 kit
|
|
Prekallikrein Activator (PKA) Ig Assay Kit
|
PW30200
|
1 kit
|
|
Prekallikrein Activator (PKA) Ig EP Assay Kit
|
PW302EP
|
1 kit
|
|
Just Positive PKA Control
|
PW51005
|
5x0.5 mL
|
|
High Positive PKA Control
|
PW52005
|
5x0.5 mL
|
|
C1q蛋白
|
A400
|
1.0 mL
|
|
C3蛋白 quidel
|
A401
|
250 µL
|
|
C4蛋白
|
A402
|
250 µL
|
|
C5蛋白
|
A403
|
250 µL
|
|
C6蛋白
|
A404
|
250 µL
|
|
C7蛋白 quidel
|
A405
|
250 µL
|
|
C8蛋白
|
A406
|
250 µL
|
|
C9蛋白 quidel(quidel corporation)代理
|
A407
|
250 µL
|
|
Factor B蛋白
|
A408
|
250 µL
|
|
Factor D蛋白
|
A409
|
250 µL
|
|
Factor H蛋白
|
A410
|
250 µL
|
|
Factor I蛋白
|
A411
|
250 µL
|
|
Factor P蛋白
|
A412
|
250 µL
|
|
C3b蛋白
|
A413
|
50 µL
|
|
C3a蛋白
|
A414
|
100 µL
|
|
C2 Depleted
|
A500
|
1.0 mL
|
|
C5 Depleted
|
A501
|
1.0 mL
|
|
C6 Depleted
|
A502
|
1.0 mL
|
|
C7 Depleted
|
A503
|
1.0 mL
|
|
C8 Depleted
|
A504
|
1.0 mL
|
|
C9 Depleted quidel
|
A505
|
1.0 mL
|
|
Factor B Depleted
|
A506
|
1.0 mL
|
|
C4 Deficient (Guinea Pig Sera)
|
A507
|
1.0 mL
|
|
C3 Depleted
|
A508
|
1.0 mL
|
|
C1q Depleted
|
A509
|
1.0 mL
|
|
Factor P Depleted
|
A512
|
1.0 mL
|
|
C4 Depleted
|
A522
|
1.0 mL
|
|
C3/C4 Depleted Serum
|
A521
|
1.0 mL
|
|
Anti-human C1q抗体
|
A201
|
100 µL
|
|
Anti-human C3a抗体
|
A203
|
100 µL
|
|
Anti-human C3 (C3c)抗体
|
A205
|
100 µL
|
|
Anti-human C3 (C3d)抗体
|
A207
|
100 µL
|
|
Anti-human iC3b (neoantigen)抗体
|
A209
|
100 µL
|
|
Anti-human C4 (C4c)抗体
|
A211
|
100 µL
|
|
Anti-human C4 (C4d)抗体
|
A213
|
100 µL
|
|
Anti-human C4 binding protein抗体
|
A215
|
100 µL
|
|
Anti-human C5抗体
|
A217
|
100 µL
|
|
Anti-human C6抗体
|
A219
|
100 µL
|
|
Anti-human C7抗体
|
A221
|
100 µL
|
|
Anti-human C9抗体
|
A223
|
100 µL
|
|
Anti-human Factor B (Ba)抗体 quidel
|
A225
|
100 µL
|
|
Anti-human Factor B (Bb)抗体
|
A227
|
100 µL
|
|
Anti-human Factor H #1抗体
|
A229
|
100 µL
|
|
Anti-human Factor I #2抗体
|
A231
|
100 µL
|
|
Anti-human Factor P #1抗体
|
A233
|
100 µL
|
|
Anti-human Factor P #2抗体
|
A235
|
100 µL
|
|
Anti-human S Protein (vitronectin)抗体
|
A237
|
100 µL
|
|
Anti-human SC5b-9 (TCC, neoantigen)抗体
|
A239
|
100 µL
|
|
Anti-human Clusterin (SP40, 40 and Apo J)抗体
|
A241
|
100 µL
|
|
Anti-human Factor I #1抗体
|
A247
|
100 µL
|
|
Anti-human C8抗体
|
A249
|
100 µL
|
|
Anti-human C3d (neoantigen)抗体
|
A250
|
100 µL
|
|
Anti-human C4d (neoantigen)抗体
|
A251
|
100 µL
|
|
Anti-human Bb (neoantigen)抗体
|
A252
|
100 µL
|
|
Anti-human C4 (C4d)抗体
|
A253
|
0.5 mL
|
|
Anti-human Factor H #2抗体
|
A254
|
100 µL
|
|
Anti-human Factor H #3抗体
|
A255
|
100 µL
|
|
Human Complement Standard quidel
|
A100
|
1.0 mL
|
|
Normal Human Complement
|
A112
|
2.5 mL
|
|
Normal Human Complement
|
A113
|
5.0 mL
|
|
Complement Activator
|
A114
|
0.2 mL
|
|
Complement Sample Panel
|
A115
|
1 ea.
|
|
Guinea Pig Serum Complement (Functional Guinea Pig Serum Complement)
|
A119
|
5.0 mL
|
|
Guinea Pig Serum Complement (Functional Guinea Pig Serum Complement)
|
A121
|
2.0 mL
|
|
Cobra Venom Factor
|
A600
|
1.0 mg
|
|
Specimen Stabilizing Solution
|
A9576
|
25.0 mL
|
|
Anti-human C1 Inhibitor抗体
|
A300
|
2.0 mL
|
|
Anti-human C1q抗体
|
A301
|
2.0 mL
|
|
Anti-human C1s抗体
|
A302
|
2.0 mL
|
|
Anti-human C2 (Ig Fraction)抗体
|
A303
|
1.0 mL
|
|
Anti-human C3抗体
|
A304
|
2.0 mL
|
|
Anti-human C4抗体
|
A305
|
2.0 mL
|
|
Anti-human C5抗体
|
A306
|
2.0 mL
|
|
Anti-human C6抗体
|
A307
|
2.0 mL
|
|
Anti-human C7抗体
|
A308
|
2.0 mL
|
|
Anti-human C8抗体 quidel
|
A309
|
2.0 mL
|
|
Anti-human C9抗体 quidel(quidel corporation)代理
|
A310
|
2.0 mL
|
|
Anti-human Factor B抗体
|
A311
|
2.0 mL
|
|
Anti-human Factor H抗体
|
A312
|
2.0 mL
|
|
Anti-human Factor I抗体
|
A313
|
2.0 mL
|
|
Anti-human C1q抗体
|
A700
|
250 µL
|
|
Anti-human C3c抗体
|
A701
|
250 µL
|
|
Anti-human C3d抗体
|
A702
|
250 µL
|
|
Anti-human C4c抗体
|
A703
|
250 µL
|
|
Anti-human C4d抗体
|
A704
|
250 µL
|
|
Anti-human C5抗体
|
A705
|
250 µL
|
|
Anti-human C6抗体
|
A706
|
250 µL
|
|
Anti-human C7抗体
|
A707
|
250 µL
|
|
Anti-human C8抗体
|
A708
|
250 µL
|
|
Anti-human C9抗体
|
A709
|
250 µL
|
|
Anti-human iC3b (neoantigen)抗体
|
A710
|
250 µL
|
|
Anti-human SC5b-9 (neoantigen)抗体
|
A711
|
250 µL
|
|
Anti-human Factor Bb抗体
|
A712
|
250 µL
|
